Introduction
This review summarizes our present understanding of the topic of neuroepigenetics in major
psychotic disorders. To elucidate the molecular mechanisms whereby nurture (biological or
environmental epigenetic factors) and nature (genetic factors) interact to cause major
psychiatric disorders such as schizophrenia (SZ) and bipolar (BP) disorder was at the center
of Dr. Costa’s mission for the last 15 years of his research at the Psychiatric Institute at the
University of Illinois at Chicago (Costa et al., 2002).
Existing drugs used to treat major psychiatric disorders have limited efficacy and substantial
side effects. Hence, the challenge for Dr. Costa and his colleagues has been to find new
ways to prevent and treat psychiatric disorders with pharmacological agents that fail to have
major unwanted side effects.NIH-PA Author Manuscript
NIH-PA Author Manuscript
NIH-PA Author ManuscriptThe challenge to identify the core pathophysiological mechanismsunderlying schizophrenia (SZ) and bipolar (BP) disorder that are targetedby antipsychoticsUnfortunately, there are few new leads for future drug development for the treatment ofmajor psychiatric disorders (Miller, 2010a). A fundamental barrier to the identification ofmore efficacious, less toxic, and faster acting drugs than those presently available to treat BPdisorder and SZ is the incomplete understanding of the etiopathogenetic mechanismsunderlying the symptomatology of these diseases.Population, family, and twin studies indicate that SZ and BP disorders are highly heritable
but a single allele conferring increased risk has been identified in only a small proportion of
the observed phenotypic variants (Li, 2010, Sullivan et al., 2008). Hence, the hypothesis that
complex psychiatric disorders are attributable to a relatively few common genetic variants
has been questioned. Rather, it appears that these disorders are the consequence of
synergistic interactions of multiple susceptibility genes with environmental neuroepigenetic
factors (Ptak and Petronis, 2008).
“Neuroepigenetics” refers to the reversible regulation of various genomic functions
mediated principally through changes in DNA methylation and chromatin structure in
neurons.
The findings reviewed in this article marshaled by the pioneering work of Costa and his
collaborators (1996–2010) suggest that an epigenetic downregulation of telencephalic
GABAergic genes may represent a contributing factor to the behavioral and cognitive
impairments experienced by SZ and BP disorder patients.
Despite the large number of pharmacological studies performed in recent years to delineate
the receptor affinity profile of different antipsychotics (Table 1) (Gary and Roth 2007,
Jarskog et al. 2007, Roth et al. 2004), little is known about the action of antipsychotics on
specific epigenetic mechanisms in GABAergic or glutamatergic neurons. In fact, the
DNA methylation and demethylation神经疾病靶点_生物学_自然科学_专业资料。Pharmacological...Epigenetic GABAergic targets in schizophrenia and bipolar disorder. Neuroph...
et al.Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder. Hum Mol Genet. 2011; 20: 4786-4796. Rogd...
et al.Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder. Hum Mol Genet. 2011; 20: 4786-4796. Rogd...
热门文档